Reimbursement
Central line infections increased by at least 46%, compared to 2019.
Patient volume increases and cost reduction measures led to significant revenue increases, which were hampered in 2020 by COVID-19.
More patients is resulting in a self-induced postponement of non-emergent surgical cases, resulting in lower hospital revenues.
The findings have implications for the healthcare industry, suggesting that another wide-scale pandemic could strain hospital staffs and resources.
A federal appeals court rejected the group’s latest attempt to get higher reimbursements for the outlier payments they received from 2008 to 2011.
The bill would remove the requirement that a provider has to be physically present when a patient receives their infusions.
ED and inpatient volumes have returned to 2019 levels, though respondents said they expect it to be roughly 5-6% higher in 2022.
CMS Administrator Chiquita Brooks-LaSure concurs with the recommendation and says CMS will further review capital payment methodology.
CMS paid an estimated $16.2 billion for unsupported diagnoses in 2016, audits of Medicare Advantage plan data show.
McKinsey & Company's Oleg Bestsennyy and Gunjan Khanna discuss payment for telehealth and how it's changing.